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ABSTRACT 
Akt signaling regulates many cellular functions that 
are essential for the proper balance between self-
renewal and differentiation of tissue-specific and 
embryonic stem cells (SCs). However, the roles of 
Akt and its downstream signaling in SC regulation 
are rather complex, as Akt activation can either 
promote SC self-renewal or depletion in a context-
dependent manner. In this review we have evidenced 
three “modes” of Akt-dependent SC regulation, 
which can be exemplified by three different SC 
types. In particular, we will discuss: 1) the 
integration of Akt signaling within the “core” SC 
signaling circuitry in the maintenance of SC self-
renewal and pluripotency (embryonic SCs); 2) 
quantitative changes in Akt signaling in SC 
metabolic activity and exit from quiescence 
(hematopoietic SCs); 3) qualitative changes of Akt 
signaling in SC regulation: signaling compartment-
talization and isoform-specific functions of Akt 
proteins in SC self-renewal and differentiation 
(limbal-corneal keratinocyte SCs). These diverse 
modes of action are not to be intended as mutually 
exclusive. Rather, it is likely that Akt proteins 
participate with multiple parallel mechanisms to 
regulation of the same SC type. We propose that 
under specific circumstances dictated by distinct 
developmental stages, differentiation programs or 
tissue culture conditions, one mode of Akt action 
prevails over the others in determining SC fates. 
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Introduction 
A stem cell (SC) is defined as an undifferentiated, 
long-lived proliferating cell with the capacity to self-
renew and to generate progenies of cells primed to 
differentiate in one or more cell types (1). With this 
dual function (or “stemness”), SCs allow the 
generation of tissues during development by 
building their basic cellular blocks, and their 
maintenance throughout lifetime by counter-
balancing the continuous loss of differentiated or 
damaged cells. 
     The search of a common set of genes (the 
“stemness” genes) among embryonic, neural and 
hematopoietic SCs has failed to reveal a gene 
expression signature accounting for the SC status in 
all cell types analyzed (2, 3), and the emerging view 
is that in different contexts, stemness is maintained 
by largely independent cellular programs, each one 
suited to couple SC self-renewal and differentiation 
abilities with distinct developmental stages, tissue 
differentiation programs and cell turnover rates (4-
6). 
     In fact, besides playing their defining roles, SCs 
are first of all cells, and must regulate fundamental 
biological functions such as the ability to survive, to 
divide and migrate, to establish contacts with 
neighboring cells and the surrounding environment 
(niche), to regulate metabolism in response to 
nutrients availability, and to respond to a variety of 
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external cues and cellular stresses. In particular, cell-
protective mechanisms coincide with many of the 
conserved signaling pathways that regulate SC self-
renewal and differentiation (7). Therefore, mainte-
nance of functional SC pools during the organism 
lifespan requires integration of SC-specific signaling 
mechanisms (the “core” SC signaling circuitries) 
with other key cellular programs, fitted to maintain 
“stemness” and tissue homeostasis in the context in 
which SCs operate. 
     Consistent with a role of SCs in aging (8), it 
seems conceivable that stemness arose during 
evolution in parallel with the emergence of long-
lived multicellular organisms, as a strategy to 
prolong lifespan via elimination and replacement of 
differentiated or damaged cells in increasingly 
complex tissues. One conserved molecular 
machinery coupling the cell 
responses to stresses and 
nutrients availability with 
the regulation of organismal 
aging and SC biology is the 
PI3K/Akt/FOXO/mTOR 
signaling network (9, 10). 
The most evolutionary 
conserved function of Akt signaling is the control of 
energy metabolism, which in mammalian cells is 
coupled to the ability to inhibit apoptosis and 
promote cell cycle progression (for review see (11, 
12). Attenuation of the insulin/IGF-1-like (IIS) 
metabolic pathway as well as caloric restriction 
extends the lifespan of nematodes, fruit flies and 
mammals (8, 9, 13, 14). Effectors of lifespan 
extension induced by inhibition of IIS are the 
forkhead box O (FOXO) family of transcription 
factors, which are under the negative control of the 
IIS/PI3K/Akt pathway (15-18). Individual or 
combined ablation of FOXO genes in mice leads to 
SCs depletion in various lineages (19-21). Inhibition 
of mTORC1, a signaling complex activated by 
IIS/Akt signaling and nutrients (22), also extends the 
lifespan of model organisms (23-25), and mTORC1 
pharmacological inhibition by rapamycin enhances 
SC functions in several contexts (26-29). Moreover, 
a conserved role of FOXOs in limiting mTORC1 
signaling by inducing the expression of mTORC1-
inhibitory proteins has also been established (30-32). 
However, in spite of the conserved functions of 
these Akt effectors pathways in organism lifespan 
and SC maintenance, the consequences of Akt 
activation in different SC types range from enhanced 
SC self-renewal (33, 34) to premature SC exhaustion 
(35, 36). In the attempt to reconcile these apparent 
paradoxes, we will provide here a simplified view of 
three diverse modalities by which Akt signaling 
regulates SC self-renewal and differentiation, 
exemplified by three different SC types.   
 
Akt proteins and activation 
Akt/PKB signaling is carried out by three 
homologous serine/threonine protein kinases 
(Akt1/PKBα, Akt2/PKBβ and Akt3/PKBγ) encoded 
by separate genes (37, 38). In response to a plethora 
of extracellular signals Akt kinases regulate 
fundamental cellular functions such as growth, 
survival, differentiation and energy metabolism (39). 
Activation of Akt kinases normally occurs 
downstream of phosphoinositide-3 kinases (PI3K). 
Full enzymatic activation is 
achieved through a sequential 
process. Akt proteins are first 
recruited to the plasma 
membrane through their 
amino-terminal pleckstrin 
homology (PH) domains at 
sites enriched of PI3K lipid 
products (PI(3,4,5)P3 or PI(3,4)P2). At the plasma 
membrane, Akt proteins are phosphorylated at two 
conserved residues, the first one within the T-loop of 
the catalytic domain (Thr308 in Akt1) by the 
phosphoinositide-dependent kinase 1 (PDK1), and 
the second one within the carboxy-terminal 
hydrophobic motif (Ser473 in Akt1) by the 
mammalian target of rapamycin complex 2 
(mTORC2) (40-42), albeit other protein kinases 
have also been found capable of phosphorylating the 
same Ser residue (43).  Although phosphorylation of 
Akt at both regulatory residues is critical for full 
kinase activation, it has been shown that in the 
absence of Ser473 phosphorylation, Akt is still 
capable to phosphorylate some, but not all its 
substrates (41). 
     Akt proteins are localized to the plasma 
membrane following activation, and once activated, 
they distribute throughout different cell 
compartments including the nucleus, whereby they 
phosphorylate a multitude of substrates to regulate 
diverse cellular functions (39). Akt kinases are 
inactivated by protein phosphatases such as the 
protein phosphatase 2A (PP2A), which 
dephosphorylates the regulatory Thr residue within 
the kinase domain (44), and the family of plekstrin 
Akt and its downstream 
signaling effector molecules 
play key roles in SC self-
renewal and differentiation,  
in a context dependent manner  
Akt-Foxo-mTOR signaling in stem cells  
www.discoveriesjournals.org 3 
homology domain leucine-reach repeat protein 
phosphatases (PHLPP1 and PHLPP2) that 
dephosphorylate the Ser residue of the hydrophobic 
motif of Akt kinases in an isoform-specific manner 
(45). 
     The overall PI3K/Akt signaling activity is 
negatively regulated by the tumor suppressor PTEN 
that dephosphorylates the PI3K lipid products, and 
by activation of the Akt downstream effector 
mTORC1, which in turn induces  negative feedback 
mechanisms that limit PI3K activation (for review 
see (46, 47). Hyperactivated Akt is a common 
feature of many human cancers (39) since, at least in 
part, it both provides protection from apoptosis and 
promotes uncontrolled cell-cycle progression (48). 
     Studies of Akt isoform-specific knockout mice 
have recently suggested that besides playing 
redundant roles in cellular signaling, Akt 
isoenzymes have also specific biological functions 
(49). Akt1 knockout mice have growth retardation 
(50) and Akt1-null cells display higher rates of 
apoptosis, indicating a critical role for Akt1 in cell 
survival (50, 51). Akt2 knockout mice develop a 
type 2 diabetes-like phenotype, and cells derived 
from those mice show impaired glucose utilization 
(52, 53), suggesting a key role for Akt2 in the 
regulation of glucose homeostasis. Consistently, 
protein interaction studies have recently confirmed 
such a metabolic function for Akt2 (54). A role for 
Akt3 in brain development has also been proposed 
since Akt3 knockout mice display decreased brain 
size (55). Moreover, during tumor development, 
Akt1 and Akt2 often act in a complementary 
opposing manner (37, 38). Specific gain of function 
of Akt2 promotes migration and invasion in breast 
cancer epithelial cells, whereas Akt1 is mostly 
involved in cell proliferation and growth (56). In 
addition, Akt2 induces epithelial to mesenchymal 
transition (57, 58), a process involved in de novo 
formation of breast cancer SCs (59). Intriguingly, 
the differential roles of Akt isoforms in breast cancer 
SC have been found associated to a differential 
regulation of microRNA of the miR200 family by 
individual Akt isoforms (60). One outstanding issue 
is how such signaling specificity is achieved in spite 
of the high structural homology of Akt isoforms.  
 
Signals downstream of Akt protein kinases in SC 
regulation: life span, metabolism and stress 
Key effectors of Akt signaling in SC regulation are 
the mTORC1 signaling complex, positively 
regulated by Akt signaling (22), and the FOXO 
family of transcription factors, which are directly 
inhibited by Akt-dependent phosphorylation (15-18). 
A persistently elevated mTORC1 activity causes an 
initial expansion followed by a later decline of 
several adult SC types (26, 61), whereas individual 
or combined ablation of FOXO genes in mice leads 
to SC depletion in various lineages (19-21). In both 
fly and mammalian cells, FOXOs can restrain 
mTORC1 activity (30, 31, 62, 63), and this 
regulatory network has been recently implicated in 
stratified epithelial SC regulation (64). Members of 
the FOXO class of transcription factors (FOXO1, -3, 
-4 and -6) regulate diverse gene expression programs 
and affect many cellular processes, including cell 
cycle regulation, cell survival and metabolism (65, 
66). Two evolutionarily conserved pathways 
regulate FOXO activity: in the presence of growth 
factors, FOXOs are negatively regulated by the 
canonical IIS signaling pathway through PI3K and 
AKT (65); FOXOs are activated instead in the 
presence of oxidative stress through Jun N-terminal 
kinase (JNK) (67). Additionally, many other 
signaling pathways and multiple post-translational 
modifications modulate FOXO activity (65-69). All 
FOXO family members bind to the consensus 
sequence (5′-TTGTTTAC-3′), and therefore are 
thought to act redundantly, although selective 
functions of specific FOXO members have also been 
described. The FOXO homologue in Caenorhabditis 
elegans, daf-16, was genetically linked to daf-2, 
which encodes an insulin type receptor, and shown 
to mediate the lifespan extension resulting from daf-
2 loss, thus providing evidence of a crucial role of 
the PI3K/Akt/FOXO signaling axis in lifespan 
control (9). FOXOs integrate a multitude of signals 
from pathways that are sensitive to environmental 
changes, and the emerging view is that these 
transcription factors behave as key regulators of 
tissue homeostasis under stressful conditions (10).  
 
1) Integration of Akt signaling within the “core” 
pluripotency signaling network in the mainte-
nance of SC self-renewal and pluripotency 
(embryonic SCs) 
Murine embryonic SCs (mES cells) are cell lines 
derived from the inner cell mass of the mouse 
blastocyst (70, 71) and can be indefinitely expanded 
in an undifferentiated, pluripotent state by the 
addition of leukemia inhibitory factor (LIF) to the 
culture medium. ES cells need to tightly balance 
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their gene expression program to prevent 
differentiation while maintaining pluripotency, 
which is executed by a gene network that is centered 
around the transcription factors OCT4, SOX2 and 
NANOG (72). In addition to activating the Jack/Stat 
and the MEK/ERK pathways, LIF also engages the 
PI3K/Akt pathway in mES cells (73). In these cells, 
ectopic expression of a myristoylated, active form of 
Akt is sufficient to maintain the pluripotent, 
undifferentiated cell phenotype in the absence of LIF 
(74). Importantly, the effects of active Akt were 
found to be reversible, since deletion of the 
transgene restored both LIF dependence and 
pluripotent cell differentiation. It has been further 
demonstrated that LIF to Akt signaling is critical for 
maintaining elevated levels of ES cell-specific 
transcription factors such as Tbx3 and Nanog (75, 
76), the latter being an essential determinant of the 
“naïve” ES cell pluripotent state (77). Moreover, Akt 
has also been reported to phosphorylate and enhance 
the transcriptional activity of Sox2 (78), another key 
factor in both ES cell pluripotency and repro-
gramming of somatic cells to induced-pluripotent 
stem cells (iPS). 
     Differently from mES cells, human ES (hES) 
cells do not depend on LIF signaling for self-renewal 
but rely on different combinations of exogenous 
factors including Activin, an agonist of Smad/2/3 
signaling (for review see (79)). In hES cells, Activin 
favors pluripotency by promoting Nanog expression 
(30, 80) but also drives mesodermal differentiation 
when PI3K/Akt signaling is low (81). hES cells can 
be maintained in a pluripotent, undifferentiated state 
under defined culture conditions requiring only three 
exogenous factors (82), Activin, and two potent 
activators of PI3K/Akt signaling, heregulin and Igf-
1. It has been shown that omission of extracellular 
Akt agonists or inhibition of Akt intracellular 
signaling promotes mesodermal differentiation. 
Since Activin/Smad2/3 signaling is also essential for 
hES self-renewal, it has been demonstrated that 
inhibition of PI3K/Akt activity skews the functions 
of Smads from self-renewal to differentiation. In 
particular, Akt activity, by restraining ERK and 
Wnt-β catenin signaling, on one hand maintains 
Smad-dependent Nanog expression, and on the other 
hand prevents Smads from activating mesodermal 
genes (82).  
Interestingly, proliferating ES cells have a metabolic 
signature that is reminiscent of that of quiescent 
hematopoietic SCs (HSCs). ES cells have a low 
mitochondrial mass compared to their differentiating 
cell progenies and cell differentiation parallels with 
a switch from glycolysis to a robust increase in 
mitochondrial oxidative activity (83).  
 
 
 
 
Figure 1.  
Schematic representation of the 
three “modes” of Akt signaling 
described in the main text:  
a) in mouse embryonic stem cells 
(mES), Akt signaling favors self-
renewal and pluripotency at the 
expenses of cell differentiation (not 
shown); b) in hematopoietic stem 
cells (HSC), quantitative changes in 
Akt signaling outputs determine 
different SC fates: normal Akt 
signaling favors self-renewal (low 
Akt signaling), while an increase of 
activity (high Akt signaling) favors 
exit from quiescence and 
commitment to differentiation c) in 
human limbal keratinocyte stem 
cells (hLSC), a different ratio 
between Akt isoforms activity in 
discrete subcellular compartments 
shifts the balance between SC self-
renewal and  differentiation. 
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Since one of the most conserved effects of Akt 
activation is the increase in cellular glucose uptake 
and stimulation of oxidative metabolism, which are 
mediated in large part by inhibition of FOXOs and 
activation of mTORC1 signaling, how ES cells 
maintain high Akt activity to promote self-renewal, 
and at the same time maintain low oxidative rates is 
currently unclear. This would suggest that Akt 
proteins, in ES cells, are decoupled from some of 
their key signaling effectors in cell metabolism. 
Intriguingly, FOXO1 has been recently shown to be 
necessary for ES cell pluripotency, and to directly 
regulate OCT4 and SOX2 expression and functions 
in an Akt-independent manner (84). How FOXO1 
can be transcriptionally activated in these rapidly 
dividing cells, and how its activity is directed 
towards OCT4 and SOX2 deserve future 
investigation. 
     In summary, increasing experimental evidence 
indicate that in both mES and hES, Akt signaling 
participates to the “core” pluripotency network by 
impinging on Nanog expression, and that gains of 
Akt activity promote pluripotency and self-renewal 
at the expenses of differentiation, in a manner that is 
decoupled from activation of Akt metabolic 
effectors. However, the identities of the direct Akt 
effectors in this context are still unknown. 
 
Differential roles of Akt signaling in tissue-
specific SCs 
In tissue-specific SCs, the long-term consequences 
of sustained Akt activation, such as that induced by 
PTEN deletion, range from enhanced SC expansion 
and maintenance like in neuronal and mammary 
gland progenitor cells (33, 34), to SC depletion in 
the hematopoietic system (35, 85). The mechanisms 
underlying these opposite roles of Akt signaling in 
different SC types are still unclear, and may include 
differential ability of Akt protein kinases to 
phosphorylate a subset of substrates under specific 
conditions, the strength and duration of Akt activity, 
the onset of negative feedbacks mechanisms, as well 
as cross talks with other key SC regulatory signaling 
pathways (Notch, Wnts, BMP, Activin/TGF-β), 
ultimately determining the choice of a SCs towards a 
specific fate.  
 
2) Akt regulation of SC metabolism and 
quiescence (Hematopoietic Stem Cells) 
Hematopoietic SCs (HSCs) are cells that give rise to 
the cellular constituents of blood for life-long. 
Although SC quiescence is not a general prerequisite 
of all stem cell types (86, 87), multipotent HSCs are 
typically slow cycling, and become activated to 
generate committed progenitor cells that replenish 
all the differentiated blood cell lineages. HSCs 
reside normally in hypoxic niches in the bone 
barrow (88), and relatively low oxygen levels 
promote SC quiescence (89, 90) and glycolytic 
metabolism at the expenses of mitochondrial 
oxidative metabolism (reviewed by (83, 91), 
whereas physiological increases in reactive-oxygen 
species (ROS) are coupled with the differentiation 
switch (20, 36, 92, 93). Proper levels of ROS and 
maintenance of reversible quiescence play thus key 
roles in long-term HSC maintenance, since virtually 
every genetic or environmental manipulation 
permanently altering these parameters usually results 
in hematopoiesis abnormalities, including leukemia 
(reviewed by (94).   
     Molecules downstream of Akt signaling, 
including FOXO transcription factors and the 
mTORC1 signaling complexes are critical mediators 
of the cell metabolic responses to changes in 
nutrients, growth factors and oxygen levels. Akt 
activation, by favoring glucose uptake metabolism, 
is a potent activator of glucose uptake and 
mitochondrial oxidative metabolism. Moreover, 
mTORC1 signaling, which is negatively regulated 
by hypoxic conditions and positively by Akt, 
signaling, stimulates mitochondrial biogenesis 
(reviewed by (95). The transcriptional activity of 
FOXO family members is stimulated by oxidative 
stress, and inhibited by Akt activation in response to 
growth factors, and FOXO target genes are crucial 
mediators of HSC quiescence, and resistance to 
oxidative stress.   
     In the hematopoietic system, PI3K/Akt/FOXO 
signaling plays critical roles in both HSC 
maintenance and lineage development (96). Several 
hematopoietic growth factors and cytokines, such as 
erythropoietin, thrombopoietin, Stem Cell Factor 
(SCF, c-kit-ligand), Flt3 ligand, activate the 
PI3K/Akt pathway. FOXOs have a crucial role in 
several types of adult stem cells and as this role 
seems to be evolutionarily conserved, since they also 
regulates SC maintenance in Hydra vulgaris (97). In 
mHSCs they favor SC maintenance and self-renewal 
ability (19, 20, 98). In addition, FOXOs may protect 
HSCs from cell death by mediating resistance to 
physiological oxidative stress thorough catalase and 
superoxide dismutase. Indeed, whereas targeted 
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deletion of FOXO in HSCs results in HSC 
exhaustion with concomitant increase in cellular 
ROS, treatment with an antioxidative agent could 
partially rescue this phenotype (20, 98). This role of 
FOXOs in maintaining the SC population over time 
also occurs in neural SCs (21, 99). Consistent with 
the suppression of PI3K/Akt signaling observed in 
HSCs, mTORC1 is downregulated in these cells and 
studies on TSC-1 knockdown have shown that 
mTORC1 inhibition is essential for HSCs 
quiescence (98, 100, 101). Besides, HSCs functions 
decline with age and this is reportedly due to 
increased mTORC1 activity (26). 
Moreover, several developmental signaling 
pathways that also regulate adult hematopoiesis 
(Wnts, Notch and BMP) (102), can potentially cross 
talk with the PI3K/Akt pathway at multiple levels. 
Quantitative abnormalities in Akt signaling have a 
deep impact on HSC biology. For instance, in 
murine HSCs, both conditional deletion of PTEN 
(35, 85) and overexpression of a constitutively 
activated myrAkt (103) cause loss of quiescence, 
transient expansion of HSCs, followed by long-term 
SC decline. Importantly, in both experimental 
settings, the exhaustion of HSCs is paralleled by the 
development of leukemia-like hematological 
disorders. On the other hand, the combined deletion 
of Akt1 and Akt2, the two main Akt isoforms 
expressed by hematopoietic cells, results in 
exaggerated SC quiescence, reduced ROS 
production, and impaired cell differentiation, 
consistent with the notion that physiological levels 
of ROS are involved in the switch between HSC 
quiescence and differentiation (104). Serial HSC 
transplantation was impaired by Akt1/Akt2 
deficiency, albeit individual deletion of either Akt 
isoform had little or no effect. Overall, these studies 
indicate that HSCs are extremely sensitive to the 
overall levels of Akt signaling output, and whereas 
normal Akt signaling is required to balance SC self- 
renewal with normal ROS production and 
differentiation, either too much or too little Akt 
activity eventually result in SC failure.  
     Several transcription factors are necessary for 
HSC self-renewal, among which GATA2, GFI1, 
TEL, JUNB, SOX17 and PU.1 (102). Although 
phosphorylation of GATA2 by Akt has been 
reported to regulate adipose cell differentiation 
(105), it is currently unknown whether a similar 
mechanism is also involved in HSCs self-renewal 
and differentiation. Inhibition of PI3K/Akt/ 
mTORC1 signaling also inhibits T cell 
differentiation, and prevents downregulation of the 
GFI1 transcription factor (106). However, whether 
or not Akt signaling plays a direct role in the 
regulation of the core HSC transcriptional network 
remains to be established.  
     On the other hand, there is accumulating 
evidence that Akt directly participates to the 
epigenetic regulation of HSCs by phosphorylating 
Bmi1, one key component of the Polycomb 
Repressor Complex 1 (PRC1), at Ser 316, thereby 
favoring de-repression of the Ink4a-Arf locus, which 
encodes for p16/Ink4a and p19/Arf proteins that 
promote cell cycle arrest and cell senescence. 
Importantly, ablation of Bmi1 in mice also leads to 
failure of several SC types including HSCs (107), 
and more in general, defects in either PRC1 or PRC2 
functions hamper SC self-renewal in several cell 
types, including HSCs (108). Akt also phosphory-
lates the EZH2 catalytic component of PRC2, 
thereby counteracting its repressive activity on gene 
expression (109). Therefore, under conditions of 
persistently elevated Akt activation, such as PTEN 
loss, HSC exhaustion may depend in part on cell 
senescence favored by loss of Polycomb repressive 
activity at the Ink4a-Arf locus. 
     It has been shown that mTORC1 inhibition by 
rapamycin rescues the exhaustion of normal HSCs 
and prevents the onset of leukemia following PTEN 
loss in vivo (35). Consistently, conditional deletion 
of the mTORC1 negative regulator TSC1 in murine 
HSCs provokes loss of SC quiescence, increased 
mitochondrial biogenesis and ROS production, with 
subsequent failure of hematopoiesis and HSC self-
renewal (101). Importantly, the effects of TSC1 
deletion were rescued by treatment of cells with 
ROS antagonists. Since Akt phosphorylates TSC1/ 
TSC2 complexes to release their inhibitory activity 
on mTORC1, these data strongly suggest that the 
PTEN/Akt/mTORC1 axis normally plays important 
roles in the normal balance between HSC self-
renewal and differentiation and in PTEN/Akt-
induced HSC exhaustion and leukemogenesis (for 
review see (95). 
     Consistently, in murine HSCs, conditional 
deletion of Raptor, an essential component of 
mTORC1, severely hampers hematopoiesis leading 
to pancytopenia, splenomegaly, extramedullary 
hematopoiesis and abnormalities in differentiation 
(110). Raptor-deficient HSCs display abnormalities 
in transplantation assays and impaired regenerative 
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potential upon sub lethal irradiation. Notably, Raptor 
depletion also halts leukemic progression in PTEN-
deficient HSCs. 
     On the other hand, the conditional deletion of 
Rictor (an essential component of mTORC2) in 
adult mice has no effects on basal hematopoiesis, but 
prevents both SC exhaustion and leukemogenesis 
induced by PTEN loss (111). These data are 
consistent with a model in which mTORC1 plays 
key roles in both normal SC maintenance and Akt-
driven SC depletion, while mTORC2, by favoring 
Akt activation from upstream, becomes a limiting 
factor in cellular processes that rely on maximal Akt 
signaling outputs, such as those causing HSC 
depletion and leukemogenesis.  
     Altogether, these studies provide compelling 
evidence that mTORC1 signaling activity is 
essential for normal hematopoiesis and represents a 
driving force behind HSC depletion and leukemia 
progression downstream of the PTEN/Akt axis.  
Thus, mTORC2 and mTORC1 appear to represent 
respectively an essential regulator and a key effector 
of Akt activation in both HSC depletion and 
leukemogenesis induced by PTEN loss. Does this 
mean that FOXOs, established regulators of HSC 
maintenance and direct Akt targets, do not play a 
role in this process? Sustained Akt activation 
downstream of PTEN loss is expected to lead to 
FOXO inactivation, and since FOXO loss of 
function per se drives HSC depletion, it is 
conceivable that also in the context of PTEN loss, 
Akt-dependent FOXO inactivation may contribute to 
SC depletion. Intriguingly, several direct FOXO 
target genes including sestrin3, (32, 112) and the 
direct TORC1 inhibitor TSC1 have the potential to 
restrain mTORC1 signaling via different 
mechanisms. Notably, this FOXO-dependent 
mTORC1 inhibition has been shown to take place 
under different experimental conditions and is 
though to represent a conserved cellular response to 
cellular stress conditions between flies to mammals 
(113). Moreover, we have recently demonstrated that 
in cultured human limbal keratinocyte SCs, the 
Akt2/FOXO/mTORC1 signaling axis is a critical 
determinant of epithelial stem cell exhaustion, at 
least in culture (64), suggesting that this cross talk 
may be important also in the regulation of other SC  
types in which robust Akt signaling to FOXO plays 
a role in SC depletion. Since both FOXOs and TSC1 
deletion in HSCs result in SC depletion and 
exaggerated ROS accumulation, and in both cases 
SC depletion is counteracted by ROS scavengers, 
this further suggests a convergence of FOXO and 
mTORC1 signaling on similar cellular process in 
HSC regulation. Therefore, it would be interesting to 
test whether or not the HSC decline induced by loss 
of FOXOs can be rescued in part by rapamycin 
treatment, like in the case of PTEN loss. Should this 
not be the case, this would suggest that FOXOs 
might become desensitized to Akt inhibition due to 
activation of other cellular pathways. It has been 
reported that in certain cellular contexts, 
transcriptional activation of FOXOs by JNK upon 
stress including oxidative damage, dominates over 
the ability of Akt to inactivate FOXOs (67). 
Clarifying the role of FOXOs in Akt-induce SC 
depletion and leukemogenesis is of key therapeutic 
relevance, since it has been recently reported that in 
Acute Myeloid Leukemia (AML) cells, FOXOs 
favors the maintenance of cells with the properties of 
leukemia-initiating cells. Unexpectedly, either Akt 
activation or FOXO inhibition induce apoptosis and 
promote myeloid differentiation of AML cells, 
reverting the established paradigm of Akt behaving 
as an oncogene, and FOXOs as tumor suppressors. 
Interestingly, AML cells that escape from Akt-
induced FOXO inactivation or loss of FOXO 
expression, become sensitive to JNK inhibitors, 
suggesting that JNK activation probably favors the 
selection of AML cells capable to withstand the loss 
of FOXOs, providing a rationale for the employment 
of JNK inhibitors in antileukemic therapy.  
Importantly, quiescence is a property shared by 
normal multipotent HSCs and Leukemia–initiating 
cells. 
 
3) Akt signaling selectivity in SC regulation: 
subcellular compartmentalization and isoform-
specific functions of Akt proteins in human 
limbal keratinocyte stem cells (hLSCs) 
The cornea is the most important light refracting 
structure of the eye, and the integrity of its stratified 
epithelium is key for visual acuity. In adult humans, 
the self-renewal of the corneal epithelium relies on 
keratinocyte SC populations that reside in the basal 
epithelial layer of the limbus, the narrow transitional 
zone at the boundaries between the cornea and the 
bulbar conjunctiva (114-121). Pathological 
conditions leading to loss of limbus integrity result 
in severe visual impairment or blindness. The 
similarities between human limbal- and epidermal 
keratinocytes, which have been extensively 
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employed in cellular therapies for treating burn 
patients, have allowed the establishment of culture 
conditions apt to propagate hLSCs ex vivo for use in 
therapeutic transplants (117, 119, 121-123). Culture 
of human limbal keratinocytes (LKs) in the presence 
of a fibroblast feeder layer (124) plus additional 
factors, including fetal bovine serum, Insulin and 
Epidermal Growth Factor, originate three types of 
colonies, namely, holoclones, meroclones and 
paraclones (117, 122), of which holoclones possess 
all the defining features of cultured SCs such as 
long-term self-renewal and the capacity to 
regenerate tissue in vivo (125, 126). We have 
recently explored the role of Akt signaling in the 
biology of hLSCs (64).  
     We have found that in human corneal tissue, the 
distribution of active Akt proteins nearly overlaps 
with that of the putative LSCs marker p63, which, 
under homeostatic conditions, is confined to the 
basal layer of the limbal epithelium (127, 128). 
Moreover, few differentiating cells moving to the 
suprabasal differentiated cell layers, expressing low 
levels of p63, also display high levels of Akt 
activation.  
     The progenies of cultured human primary limbal 
keratinocyte holoclones have also higher Akt 
activity as compared to those generated SC-depleted 
clones. We found that a transient inhibition of PI3K 
or Akt activity impairs the clonogenic potential of 
the progenies of treated cells in spite of having little 
or no effects on the cell cycle, suggesting that PI3K 
to Akt signaling has important roles in LSC self-
renewal.  
     By investigating the roles of Akt1 and Akt2, the 
two Akt isoforms expressed in LKs, we found that 
whereas Akt1 silencing anticipated SC exhaustion, 
Akt2 depletion had an unexpected effect on cultured 
LSCs self-renewal ability, since it significantly 
enhanced both clonogenic potential and lifespan of 
cultured cells and interfered with differentiation and 
senescence cellular programs. Consistently, in Akt2-
deficient mice, the amounts of progenitor cells 
expressing the p63 limbal stem cell marker is 
increased, suggesting that Akt2 deficiency also 
affects LSC biology in vivo. 
     Our data indicated that signaling specificity 
rather than drops in global Akt activity underlies the 
SC phenotype of Akt2-deficient LKs, since their 
sustained self-renewal ability can be selectively 
reverted by ectopic re-expression of a normal Akt2 
protein, but not by comparable levels of either 
kinase-dead Akt2 or wild-type Akt1. Akt2 depletion 
selectively attenuates growth factors signaling to 
both FOXOs and mTORC1, albeit in a hierarchical 
manner, whereby an increase in FOXOs expression 
and transcriptional activity leads to mTORC1 
inhibition by promoting the expression of its 
negative regulator TSC1. Thus, our work provides 
direct evidence that the conserved FOXO/mTORC1 
axis participate to SC regulation, and that at least in 
this particular SC type, one single hit (Akt2 
depletion) is sufficient to enhance FOXO functions 
and to restrain mTORC1 activity. 
     Our work has indicated that the mechanistic bases 
of the differential effects of Akt1 and Akt2 reside 
mostly in their differential subcellular distribution; 
whereas Akt2 protein is both nuclear and cytosolic, 
Akt1 is found almost exclusively in the cytosol, but 
when its expression is enforced in the nuclear 
compartment via a nuclear localization signal 
peptide, Akt1 acquires the ability to revert the SC 
phenotype of Akt2-deficient cells and to 
phosphorylate FOXO molecules. These data suggest 
that is not Akt2 per se, but rather its nuclear 
distribution that drives LSC depletion. 
     Our study opens up many additional questions 
that need to be addressed to shed light on the 
complexity of Akt functions in SC regulation. Does 
the effect of Akt2 depletion reflect the well-
established role of Akt2 in metabolism control? 
Consistent with the notion that oxidative stress 
represents one major determinant of cultured cell 
senescence (29), our unpublished data indicate that 
Akt2-depleted LSCs display enhanced resistance to 
oxidative damage. It is worth remembering that the 
ocular surface is highly exposed to oxidative stress 
(7), and that corneal epithelial cells have large stores 
of glycogen that is used as a primary energy source. 
Akt signaling has been recently shown to couple 
hypoxic signaling with glycogen metabolism in the 
limbal-corneal tissue (129). It would be interesting 
to investigate how individual Akt isoforms regulate 
these functions in the context of LSC self-renewal 
and differentiation. 
     Another key issue is to better understand the 
molecular determinants of Akt proteins nuclear 
distribution. This aspect of research seems 
particularly relevant for SC biology since it would 
explain how Akt proteins are targeted to 
transcriptionally active FOXO proteins as well as to 
other nuclear targets potentially involved in SC 
regulation. However, the molecular determinants of 
Akt-Foxo-mTOR signaling in stem cells  
www.discoveriesjournals.org 9 
Akt isoforms nuclear distribution are still poorly 
understood, and the possible underlying mechanisms 
include phosphorylation, ubiquitylation and 
interaction with specific protein partners (38, 130). 
     How nuclear Akt signaling integrates in the core 
transcriptional programs and epigenetic regulation of 
LSCs and other SC types regulated by similar 
control mechanisms (such as for instance epidermal 
keratinocyte SCs)? Our work suggests a tight 
correlation between PI3K/Akt/FOXO signaling and 
p63 regulation, and Akt2-depleted cells express high 
levels of ∆Np63α the p63 isoform most involved in 
the regulation epithelial SC proliferative potential 
(131). Previous work has indicated that PI3K 
signaling positively regulates p63 expression at the 
transcriptional level (132). Moreover, the IIS/FOXO 
pathway has been recently shown to regulate p63- 
dependent gene expression in the establishment of 
epidermal stratification during mouse development 
(133). Our work suggests that p63 may be both 
positively and negatively regulated by Akt signaling, 
and these findings may have translational 
implications in regenerative medicine, since high 
levels of ∆Np63α expression correlate with the 
success of cultured LSC grafts in therapeutic settings 
(119, 126). 
     Notably, our studies indicating that Akt2 opposes 
normal epithelial SC functions are apparently at 
odds with the notion that in a human immortalized 
breast cell lines, Akt2 favors de novo formation of 
cancer SCs (57-60). Hence, we believe that caution 
should be taken when interpreting the biological 
function of Akt signaling in normal epithelial cells 
or in immortalized and/or transformed cell lines that 
already evaded fail-safe mechanisms of tumor 
suppression. 
 
Conclusions 
PI3K/Akt signaling has been shown to either 
promote or oppose SC maintenance. Although a 
large number of studies indicate a close link between 
metabolic pathways and SC regulation by Akt 
kinases, we still have a very limited understanding 
about the integration of these processes by Akt 
family members. In this review, we have provided 
three different examples of modalities (Figure 1) by 
which Akt signaling regulates SCs in three different 
biological contexts. These diverse “modes” of Akt 
action are not to be intended as mutually exclusive. 
On the contrary, it is likely that Akt proteins 
participate with multiple parallel mechanisms to 
regulation of the same SC type. We propose that 
under specific circumstances dictated by distinct 
developmental stages, differentiation programs or 
tissue culture conditions, one “mode” of Akt action 
prevails over the others in determining the SC fate. 
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